Wolfgang Miesbach: Jan Astermark at the BIC 2025 Presented Potentially the First Oral FVIII Mimetic Treatment for Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on Linkedin:
”For decades, oral protein delivery has failed.
Jan Astermark at the BIC meeting 2025 presented comprehensive information on oral factor VIII bispecific treatment for haemophilia A – potentially the first oral FVIII mimetic treatment!
Why is this so groundbreaking?
For decades, oral protein delivery has failed due to three major barriers:
- Large molecular size (poor absorption/bioavailability)
- GI instability (narrow pH tolerance, variable factors)
- High hydrophilicity (can’t cross membrane barriers)
This innovative Inno8 approach systematically addresses each challenge: ✨
- Optimized size (~30 kDa) via albumin binding technology
- Enhanced stability through protraction and pH optimization
- SNAC absorption enhancement for membrane permeability
- Extended half-life (115h terminal half-life!)
- Once-daily dosing potential with reduced variability
Inno8 successfully balances all critical aspects for an oral hemophilia drug – Size ✓ Potency ✓Stability ✓ PK ✓ – currently advancing through Phase 1 clinical trials for both patients with and without inhibitors.”
Stay updated on all coming congresses and seminars in the field of bleeding disorders with Hemostasis Today.
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications
-
Jan 6, 2026, 09:52Antoine Francis: Plasma is Not Just Another Component of Healthcare…
-
Jan 6, 2026, 09:45Hurry to Join EHC Youth Leadership Workshop 2026
-
Jan 6, 2026, 09:41Andrew Petrosoniak Makes It to N1 on EMCases Best of 2025!
-
Jan 6, 2026, 09:35Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
-
Jan 6, 2026, 09:30Wolfgang Miesbach: Excellent 4-Year Data of Etranacogene Dezaparvovec in Haemophilia B
-
Jan 6, 2026, 09:09Abdulrahman Nasiri: A New Perspective on Avatrombopag in Aplastic Anemia